From the American Society for Dermatological Surgery –
New statistics released today by the American Society for Dermatologic Surgery (ASDS) demonstrate the broad scope of practice and breadth of experience of dermatologic surgeons. In addition to more than 2.6 million skin cancer treatments in 2011, ASDS members continue to be… Read More
Houston, TX – February 3, 2012 – Genentech announced that Erivedge ™ (vismodegib) capsule was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with basal cell carcinoma (BCC, a type of skin cancer.) Erivedge™ was approved on January 30, 2012.
Dr. Leonard H. Goldberg,… Read More
New treatments have been approved for for both actinic keratoses and basal cell carcinoma. From Skin and Allergy News:
“The Food and Drug Administration approved two strengths of ingenol mebutate gel for the treatment of actinic keratoses Jan. 23.
The 0.015% formulation of ingenol mebutate gel (Picato) was
… Read More